NYSE:JNJ - New York Stock Exchange, Inc. - US4781601046 - Common Stock - Currency: USD
Overall JNJ gets a fundamental rating of 6 out of 10. We evaluated JNJ against 198 industry peers in the Pharmaceuticals industry. While JNJ has a great profitability rating, there are some minor concerns on its financial health. JNJ is not valued too expensively and it also shows a decent growth rate. Finally JNJ also has an excellent dividend rating. This makes JNJ very considerable for dividend investing!
Industry Rank | Sector Rank | ||
---|---|---|---|
ROA | 11.26% | ||
ROE | 27.92% | ||
ROIC | 13.67% |
Industry Rank | Sector Rank | ||
---|---|---|---|
OM | 26.16% | ||
PM (TTM) | 24.41% | ||
GM | 68.34% |
Industry Rank | Sector Rank | ||
---|---|---|---|
Debt/Equity | 0.63 | ||
Debt/FCF | 2.57 | ||
Altman-Z | 3.98 |
Industry Rank | Sector Rank | ||
---|---|---|---|
Current Ratio | 1.26 | ||
Quick Ratio | 1.03 |
Industry Rank | Sector Rank | ||
---|---|---|---|
PE | 14.56 | ||
Fwd PE | 13.09 |
Industry Rank | Sector Rank | ||
---|---|---|---|
P/FCF | 17.29 | ||
EV/EBITDA | 11.21 |
Industry Rank | Sector Rank | ||
---|---|---|---|
Dividend Yield | 3.34% |
146.36
-2.08 (-1.4%)
Industry Rank | Sector Rank | ||
---|---|---|---|
Dividend Yield | 3.34% |
Industry Rank | Sector Rank | ||
---|---|---|---|
PE | 14.56 | ||
Fwd PE | 13.09 | ||
P/S | 3.94 | ||
P/FCF | 17.29 | ||
P/OCF | 14.21 | ||
P/B | 4.51 | ||
P/tB | N/A | ||
EV/EBITDA | 11.21 |
Industry Rank | Sector Rank | ||
---|---|---|---|
ROA | 11.26% | ||
ROE | 27.92% | ||
ROCE | 17.09% | ||
ROIC | 13.67% | ||
ROICexc | 18.54% | ||
ROICexgc | 72.98% | ||
OM | 26.16% | ||
PM (TTM) | 24.41% | ||
GM | 68.34% | ||
FCFM | 22.8% |
Industry Rank | Sector Rank | ||
---|---|---|---|
Debt/Equity | 0.63 | ||
Debt/FCF | 2.57 | ||
Debt/EBITDA | 1.61 | ||
Cap/Depr | 60.47% | ||
Cap/Sales | 4.94% | ||
Interest Coverage | 250 | ||
Cash Conversion | 80.81% | ||
Profit Quality | 93.4% | ||
Current Ratio | 1.26 | ||
Quick Ratio | 1.03 | ||
Altman-Z | 3.98 |